Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marta Prelli
Observed name:
PRELLI, MARTA
Institution:
Candiolo Cancer Institute
Observed institutions:
Candiolo Cancer Institute,
University of Turin
ORCID:
0000-0001-6099-3014
Observed ORCID:
0000-0001-6099-3014
OpenAlex ID:
A5033496555
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas
2023
·
Francesca De Bacco
, Francesca Orzan
, et al.
·
Cell Reports
·
13
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription
2025
·
Francesca Pagani
, Francesca Orzan
, et al.
·
Acta Neuropathologica
·
10
Two conserved glycine residues in mammalian and Dictyostelium Rictor are required for mTORC2 activity and integrity
2019
·
Barbara Pergolizzi
, Cristina Panuzzo
, et al.
·
Journal of Cell Science
·
7
PDF
Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumors
2023
·
Francesca De Bacco
, Francesca Orzan
, et al.
·
STAR Protocols
·
3
Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution
2026
·
Marta Prelli
, Francesca De Bacco
, et al.
·
EMBO Molecular Medicine
PDF
This repository contains the R analysis scripts accompanying the research paper "Ex vivo therapy-driven selection of glioblastoma stem-like cells models therapy-specific resistance evolution." The code implements computational workflows used to process and analyze transcriptomic (RNA-seq) data derived from ex vivo glioblastoma (GBM) stem-like cell models under selective therapeutic pressure. The primary objective of these workflows is to characterize cellular deconvolution, differential gene expression, and pathway enrichment associated with therapy-specific resistance evolution.
2026
·
Boccaccio, Carla
, Orzan, Francesca Noemi
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Standard therapy boosts glioblastoma stem-like cell resistance to apoptosis and confers sensitivity to BH3 mimetics
·
PRELLI, MARTA
·
Institutional Research Information System University of Turin (University of Turin)
PDF
Show more works
View as search
Works count:
7
Citation count:
33
H-index:
3
I10-index:
2
Year
Topic
Type